Benitec Biopharma Limited (BNTC) vs EyePoint, Inc. (EYPT)

Benitec Biopharma Limited and EyePoint, Inc. are both Biotechnology companies. Benitec Biopharma Limited and EyePoint, Inc. are of similar size ($336.2M and $324.2M). Benitec Biopharma Limited grew revenue faster over the last twelve months: −1.32% against −94.6%. Benitec Biopharma Limited has the higher net margin (0.00% vs −10,998.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Benitec Biopharma Limited leads on 11 and EyePoint, Inc. on 6.

Valuation

Metric BNTC EYPT Biotechnology median
P/E n/m n/m 7.88
P/S 5,953.22 112.37 11.47
P/B 2.52 1.88 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 3,555.62 49.88 10.73
Earnings yield (10.25%) (103.31%) (28.84%)
Free cash flow yield (3.72%) (86.54%) (23.03%)

Profitability

Metric BNTC EYPT Biotechnology median
Gross margin 0.00% 41.75% 65.16%
Operating margin 0.00% (11,369.30%) 0.00%
Net margin 0.00% (10,998.67%) 0.00%
Free cash flow margin 0.00% (9,724.68%) 0.00%
Return on equity (33.21%) (148.70%) (57.72%)
Return on assets (32.28%) (115.86%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BNTC EYPT Biotechnology median
Revenue growth (TTM) (1.32%) (94.63%) 5.64%
EPS growth (last fiscal year) 6.83% (36.64%) —
Revenue growth, 5-year CAGR 4.92% (1.85%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTC EYPT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 34.00 4.50 4.73
Net debt to EBITDA 3.52 1.24 0.96

Dividend

Metric BNTC EYPT Biotechnology median
Dividend yield — 1.26% 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BNTC EYPT Biotechnology median
Market cap 336.24m 324.15m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack